The size of the Psychiatry Therapies Market in the Asia Pacific is estimated to expand at a high rate from 2022 to 2027.
Psychiatry is a branch of medicine that deals with mental illnesses and treats them through pharmaceutical therapy. In addition to drug therapy, psychiatrists use several psychosocial treatments to help patients. The modern Asian Pacific population is increasingly focused on work and life outside of themselves. As a result, people have more mental health problems than ever before, and self-care is neglected.
The increase in the frequency of mental diseases, the rise in the geriatric population, and the expansion of mental health awareness programs are a few factors accelerating the psychiatry therapies market in the APAC region. Furthermore, the mental health market is rising due to increased awareness of mental diseases due to education and campaigning for tremendous respect for human rights and less stigma.
According to the World Health Organization, mental illness affects one out of every four people. Given the growth in work pressure in the Asia Pacific, this trend is expected to continue. People are devoting less time to themselves, thus affecting their mental health. Mental treatment should be sought out more regularly in the future, given the expanding needs of the Asia Pacific workforce.
Individuals with poor mental health are at risk due to the pandemic, which includes an increase in mental illness, disruption of treatment, medications, and lifeline support services, as well as a negative impact on the market. In addition, a shortage of competent experts in rural areas, increased public health awareness, healthcare infrastructure, and an increase in the number of patients with fewer medical facilities are all further estimated to be limiting the market.
This research report on the Asia Pacific psychiatry therapies market has been segmented and sub-segmented into the following categories:
By Psychology Type:
By Type of Medication:
By Type of Therapy:
Regionally, Asia Pacific has the third-largest market for psychiatry therapy globally by share. It is also the fastest-growing region globally, owing to factors such as rising awareness about mental health and changing lifestyles. In addition, factors such as the growing prevalence of psychological ailments and stress levels are expected to result in the growth of this market.
Asia Pacific countries are predicted to develop at the fastest rate in this market as people become more conscious of the importance of mental health. Regional governments are also in charge of large-scale healthcare provision for their citizens. In the future, these locations are expected to provide psychiatric counseling, among other services.
Furthermore, specific countries, such as India and China, are investing in cutting-edge technology and telecommunications and hiring more mental health specialists. As a result, it will positively impact the foreseeable future.
Regionally, countries like India and China are growing in income, and many product-based businesses are developing health practices. Because of the rise in patients, healthcare professionals and corporate employees are affected. Furthermore, an increase in mental health activities in the healthcare sector to produce novel services and the existence of key players operating in the region contribute to the market's regional expansion.
KEY MARKET PLAYERS:
Companies playing a pivotal role in the Asia Pacific psychiatry therapies market are AstraZeneca, Universal Health Services Inc., Johnson & Johnson, Pfizer, GlaxoSmithKline, Eli Lilly, Bristol-Meyer Squibb, Wyeth, Astellas Pharma Inc., and others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.1 Social Psychology
5.1.2 Abnormal Psychology
5.1.3 Biological Psychology
5.1.4 Other Types
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Type of Medication
5.2.5 Mood Stabilisers
5.2.7 Other Types of Medication
5.2.8 Y-o-Y Growth Analysis, By Type of Medication
5.2.9 Market Attractiveness Analysis, By Type of Medication
5.2.10 Market Share Analysis, By Type of Medication
5.3 Type of Therapy
5.3.2 Cognitive Behavioural Therapy
5.3.3 Family Therapy
5.3.5 Group Therapy
5.3.6 Relationship Counselling
5.3.7 Interpersonal Therapy
5.3.8 Behavioural Activation
5.3.9 Other Types of Therapy
5.3.10 Y-o-Y Growth Analysis, By Type of Therapy
5.3.11 Market Attractiveness Analysis, By Type of Therapy
5.3.12 Market Share Analysis, By Type of Therapy
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Type
22.214.171.124 By Type of Medication
126.96.36.199 By Type of Therapy
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Type
184.108.40.206 By Type of Medication
220.127.116.11 By Type of Therapy
6.1.5 Market Share Analysis
18.104.22.168 By Type
22.214.171.124 By Type of Medication
126.96.36.199 By Type of Therapy
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Universal Health Services Inc.
8.3 Johnson & Johnson
8.6 Eli Lilly
8.7 Bristol-Meyer Squibb
8.9 Astellas Pharma Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.